Prime Medicine (PRME) Assets (2021 - 2026)

Prime Medicine has reported Assets for 6 years, with the latest figure at $294.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 10.19% year-over-year to $294.7 million; the trailing twelve-month figure through Mar 2026 stood at $294.7 million (down 10.19% YoY), and the FY2025 full-year result was $342.7 million, up 15.2% from the prior year.
• Assets for Q1 2026 stood at $294.7 million, down from $342.7 million in the prior quarter.
• The five-year high for Assets was $385.0 million in Q3 2025, with the low at $193.9 million in Q4 2023.
• Historically, Assets has averaged $295.8 million across 5 years, with a median of $297.5 million in 2024.
• Annual changes were most pronounced in 2023 — Assets tumbled 46.2% — and 2024, when it jumped 53.47%.
• Prime Medicine's Assets stood at $360.3 million in 2022, then sank by 46.2% to $193.9 million in 2023, then surged by 53.47% to $297.5 million in 2024, then gained by 15.2% to $342.7 million in 2025, then slipped by 14.01% to $294.7 million in 2026.
• The last three Assets figures came in at $294.7 million (Q1 2026), $342.7 million (Q4 2025), and $385.0 million (Q3 2025), per Business Quant data.